Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2011; 106(01): 178-179
DOI: 10.1160/TH11-01-0042
DOI: 10.1160/TH11-01-0042
Letters to the Editor
Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran
Further Information
Publication History
Received: 27 January 2011
Accepted after major revision: 05 March 2011
Publication Date:
24 November 2017 (online)
-
References
- 1 Adams HP, Jr del Zoppo G, Alberts MJ. et al American Heart Association; American Stroke Association Stroke Council; Clinical Cardiology Council; Cardiovascular Radiology and Intervention Council; Athero sclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655-1711.
- 2 Connolly SJ, Ezekowitz MD, Yusuf S. et al. RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fribrillation. N Engl J Med 2009; 361: 1139-1151.
- 3 Dempfle CE, Hennerici MG. Dabigatran and stroke thrombolysis. Cerebrovasc Dis 2010; 30: 203-205.
- 4 van Ryn J, Stangier J, Haertter S. et al. Dabigatran et- exilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010; 103: 1116-1127.
- 5 Lindahl TL, Baghaei F, Fagerberg Blixter I. et al. and from the expert group on coagulation of the External Quality Assurance in Laboratory Medicine in Sweden. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays. Thromb Haemost 2011; 105: 371-378.
- 6 Boehringer Ingelheim Canada. Pradrax™ Product Monograph, rev.. Burlington: Boehringer Ingelheim Canada; 2009
- 7 De Smedt A, De Raedt S, Nieboer K. et al. Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in a Stroke Patient Treated with Dabigatran. Cerebrovasc Dis 2010; 30: 533-534.